| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $28.6M | +12.4% |
| SG&A Expense | $16.1M | +8.1% |
| Operating Income | -$44.7M | +1.6% |
| Interest Expense | $4.0M | -4.1% |
| Pre-tax Income | -$44.4M | +2.7% |
| Income Tax | $43K | +43.3% |
| Net Income | -$44.5M | +2.7% |
| EPS (Basic) | -$0.78 | +41.8% |
| EPS (Diluted) | -$0.78 | +41.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49.5M | +0.4% |
| Short-term Investments | $43.7M | +29.2% |
| Current Assets | $94.7M | +7.7% |
| Total Assets | $95.6M | +7.3% |
| Current Liabilities | $4.5M | +7.8% |
| Long-term Debt | $31.1M | +3.3% |
| Total Liabilities | $35.6M | +3.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.4M | +35.3% |
| Investing Cash Flow | -$8.4M | -172.5% |
| Financing Cash Flow | $44.9M | -6.3% |
| Stockholders' Equity |
| $60.0M |
| +9.5% |